What is the drug Ibritumomab used for?
•
3 min read
Ibritumomab, sold under the brand name Zevalin, is a specialized radioimmunotherapy drug that was FDA-approved in 2002 for treating certain types of B-cell non-Hodgkin's lymphoma (NHL). The treatment delivers targeted radiation directly to cancerous cells via a monoclonal antibody, making it a powerful tool in cancer therapy.
